Press releases Press releases14 September 202614 September 2026parDIAGNOSNo Comments Post navigation Previous PostDIAGNOS Inc. – Betweenplays StockMarket Strategies Interview – September 9, 2026 Next PostDIAGNOS annonce que l’assemblée générale des actionnaires aura lieu le 30 septembre 2026 Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-to-expedite-application-for-Medical-Device-License-to-Health-Canada-and-US-FDA-related-to-its-4-new-analysis-modules^J-and-is-planning-ISO-27001-certification" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules^J and is planning ISO 27001 certification Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 06 2026 Cindy Mercier Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-celebrates-the-launch-of-Labticians-new-screening-service-for-diabetic-retinopathy-in-Ontario-and-renews-its-distribution-agreement" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2024 DIAGNOS DIAGNOS celebrates the launch of Labticians new screening service for diabetic retinopathy in Ontario and renews its distribution agreement Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-to-expedite-application-for-Medical-Device-License-to-Health-Canada-and-US-FDA-related-to-its-4-new-analysis-modules^J-and-is-planning-ISO-27001-certification" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules^J and is planning ISO 27001 certification Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 06 2026 Cindy Mercier Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-celebrates-the-launch-of-Labticians-new-screening-service-for-diabetic-retinopathy-in-Ontario-and-renews-its-distribution-agreement" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2024 DIAGNOS DIAGNOS celebrates the launch of Labticians new screening service for diabetic retinopathy in Ontario and renews its distribution agreement Download PDF
